Unichem Laboratories Limited

UNICHEMLAB

INE351A01035

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:53 2024-07-12 am EDT			5-day change	1st Jan Change
531 ^INR	-0.79%		-0.68%	+30.51%

Jun. 27	Drugmaker Servier loses EU court fight over pay-for-delay deals	RE
Jun. 27	EU top court rejects Servier appeal against EU antitrust fine	RE

Unichem Laboratories Limited Announces Resignation of Ajay Koduri as Internal Auditor, Effective June 17, 2024

June 17, 2024 at 07:17 am EDT

Unichem Laboratories Limited announced resignation of Ajay Koduri as Internal Auditor. Resignation is due to personal reasons. The Company has accepted his resignation and will be relieved from his duties with effect from June 17, 2024.

Latest news about Unichem Laboratories Limited

Drugmaker Servier loses EU court fight over pay-for-delay deals	Jun. 27	RE
EU top court rejects Servier appeal against EU antitrust fine	Jun. 27	RE
Unichem Laboratories Limited Announces Resignation of Ajay Koduri as Internal Auditor, Effective June 17, 2024	Jun. 17	CI
Unichem Laboratories Limited Announces the Resignation of Sandip Ghume as Deputy Chief Financial Officer, Effective June 30, 2024	May. 31	CI
Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 22	CI
Unichem Laboratories Limited Announces Board Resignations, Effective March 31, 2024	Mar. 29	CI
Unichem Laboratories Chief Commercial and International Business Development Officer Steps Down	Mar. 27	MT
Unichem Laboratories Limited Announces Resignation of Santosh Mahil as Chief Commercial & International Business Development Officer	Mar. 27	CI
Unichem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 05	CI
Indian Equities Close Marginally Higher Ahead of IT Earnings	Jan. 11	MT
Unichem Laboratories Gets US FDA Approval for Generic Hypertension Drug	Jan. 11	MT
Unichem Laboratories Limited Receives Anda Approval for Its Doxazosin Tablets USP, 1 Mg, 2 Mg, 4 Mg and 8 Mg	Jan. 11	CI
Unichem Laboratories Completes Sale of Entire Stake in Optimus Drugs	Dec. 05	MT
Unichem Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 01	CI
Ipca Laboratories Limited completed the acquisition of 19.29% stake in Unichem Laboratories Limited for INR 6 billion.	23-09-07	CI
Unichem Laboratories Gets US FDA Nod for Prasugrel Tablets	23-08-29	MT
Unichem Laboratories Limited Receives ANDA Approval for its Prasugrel Tablets USP, 5 Mg and 10 Mg from the United States Food and Drug Administration	23-08-29	CI
Unichem Laboratories Limited Announces the Resignation of Dilip Kunkolienkar as Member of the Audit Committee and Risk Management Committee of the Board of Directors	23-08-09	CI
Ipca Laboratories Acquires 33% Stake in Unichem for INR9.45 Billion	23-08-02	MT
Unichem Laboratories Trims Consolidated Net Loss in Fiscal Q1	23-07-14	MT
Unichem Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-14	CI
Unichem Laboratories Swings to Loss in Fiscal Q4	23-05-24	MT
Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-23	CI
Transcript : Ipca Laboratories Limited, Unichem Laboratories Limited - M&A Call	23-04-25
Ipca Laboratories to Acquire 33% Stake in Unichem for INR10.3 Billion	23-04-25	MT

Chart Unichem Laboratories Limited

Duration

Period

More charts

Company Profile

Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.

Sector

Pharmaceuticals

Calendar

2024-07-28 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
UNICHEM LABORATORIES LIMITED	+30.51%	448M
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+40.42%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.66%	247B
NOVARTIS AG	+17.90%	228B
AMGEN INC.	+14.86%	177B
PFIZER, INC.	+0.45%	164B